Menu
Back to User profile » Prof. Dr. Xian-Shu Gao
Papers published by Prof. Dr. Xian-Shu Gao:
Partial Stereotactic Ablative Boost Radiotherapy in Bulky Non-Small Cell Lung Cancer: A Retrospective Study [Corrigendum]
Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY
OncoTargets and Therapy 2020, 13:1185-1186
Published Date: 11 February 2020
Intra-rectal use of epinephrine in radiotherapy of prostate cancer
Qin SB, Gao XS, Li HZ, Liu CX, Hou DL, Nian WD, Li XY, Wang D
Cancer Management and Research 2019, 11:4847-4854
Published Date: 27 May 2019
Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
Li XY, Hong X, Gao XS, Gu XB, Xiong W, Zhao J, Yu HL, Cui M, Xie M, Bai Y, Sun SQ
Cancer Management and Research 2018, 10:3149-3158
Published Date: 31 August 2018
Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study
Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY
OncoTargets and Therapy 2018, 11:2571-2579
Published Date: 8 May 2018
Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study
Gu X, Gao X, Cui M, Xie M, Ma M, Qin S, Li X, Qi X, Bai Y, Wang D
Cancer Management and Research 2018, 10:1061-1067
Published Date: 8 May 2018
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M
OncoTargets and Therapy 2016, 9:4805-4813
Published Date: 2 August 2016